v3.26.1
SEGMENT INFORMATION - Schedule of Information About Reported Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
SEGMENT INFORMATION      
Revenue $ 149,157 $ 74,890 $ 71,348
Total Cost of revenues 76,849 20,729 19,643
Gross profit 72,308 54,161 51,705
Research and development - Direct 6,584 12,771 9,515
Loss from operations (31,436) (34,563) (30,554)
General and Administrative 49,702 30,322 25,426
General and Administrative 31,512    
Other income, net (716) (2,549) (5,789)
Interest expense 8,415 7,286 5,424
Loss on extinguishment of debt   4,427  
Net loss (39,135) (43,727) (30,189)
Operating segment      
SEGMENT INFORMATION      
Revenue 149,157 74,890 71,348
Total Cost of revenues 76,849 20,729 19,643
Gross profit 72,308 54,161 51,705
Selling, General and Administrative, Direct 65,648 45,631 47,318
Research and development - Direct 6,584 12,771 9,515
Loss from operations 76 (4,241) (5,128)
Med Device | Operating segment      
SEGMENT INFORMATION      
Revenue 62,180 70,445 71,348
Total Cost of revenues 16,464 17,516 19,643
Gross profit 45,716 52,929 51,705
Selling, General and Administrative, Direct 36,120 44,777 47,318
Research and development - Direct 6,353 12,758 9,515
Loss from operations 3,243 (4,606) $ (5,128)
Clinic Service | Operating segment      
SEGMENT INFORMATION      
Revenue 86,977 4,445  
Total Cost of revenues 60,385 3,213  
Gross profit 26,592 1,232  
Selling, General and Administrative, Direct 29,528 854  
Research and development - Direct 231 13  
Loss from operations $ (3,167) $ 365